All Patients (n=18) |
A) Neonates and Children < 15 Years with Comorbidity (n=3) |
B) Children < 15 Years without Comorbidity (n=5) |
C) Adult Patients >15 years (n=10) |
p B vs C | p B vs A | |
---|---|---|---|---|---|---|
Male sex (n,%) | 10 (55.55) | 2 (66.66) | 2 (40.00) | 6 (60.00) | 0.60* | 0.99* |
Reims urban district (n,%) | 13 (72.22) | 1 (33.33) | 4 (80.00) | 8 (80.00) | 0.99* | 0.46* |
Comorbidity (n,%) | 5 (27.77) | 2 (66.66) | 0 (0) | 3 (30.00) | 0.50* | 0.10* |
Apyrexia (n,%) | 5 (27.77) | 1 (33.33) | 2 (40.00) | 2 (20.00) | 0.56* | 0.99* |
Absence of neck stiffness (n,%) | 9 (50.00) | 2 (66.66) | 3 (60.00) | 4 (40.00) | 0.60* | 0.99* |
Median CRP (mg/L) [range] | 16 [0.6-108] | 55 [10.4-108] | 26.5 [16-40] | 12.5 [0.6-58] | 0.25 | 0.47 |
Median White Blood cells count Blood(G/L) [range] |
10.8 [4.7-22.2] | 16.7 [13-22] | 10.1 [9.9-15.4] | 10.6 [4.7-16.7] | 0.99 | 0.07 |
Median White Blood cells count CSF(n/mm3) [range] |
67.5 [0-870] | 35 [35-90] | 26 [1-198] | 149 [0-870] | 0.32 | 0.65 |
Median Protein concentration (mg/L) [range] |
424 [166-1240] | 1108 (684-1240] | 198 [166-520] | 424 [264-1040] | 0.02 | 0.02 |
CSF interferon alpha level >2UI/ml (n,%) | 8 (44.44) | 1 (33.33) | 1 (20.00) | 6 (60.00) | 0.55* | 0.99* |
Median EV RT-PCR turnaround time (hours) [range] |
47 [7-120] | 21 [7-46] | 48 [30-51] | 50 [18-120] | 0.38 | 0.09 |
Discharged before EV RT-PCR Results released (n,%) |
8 (44.44) | 0 (0) | 5 (100.00) | 3 (30.00) | 0.02* | 0.01* |
Brain imaging prescribed (n,%) | 6 (33.33) | 1 (33.33) | 0 (0) | 5 (50.00) | 0.10* | 0.37* |
Median Hospitalization length (days) [range] |
3.5 [1-14] | 12 [7-14] | 2 [1, 2] | 4 [2-5] | 0.003 | 0.01 |
Anti infective treatment prescribed§ (n,%) |
7 (38.80) | 3 (100.00) | 0 (0) | 4 (40.00) | 0.23* | 0.01* |
Post-lumbar puncture intracranial hypotension (n,%) |
1 (5.55) | 0 (0) | 1 (20.00) | 0 (0) | 0.33 | 0.99* |